Using state of the art genetic manipulation techniques to engineer cells, InSCREENeX offers novel, user friendly, mammalian cell systems as decision tools for drug development processes. These complementary, cellular screening tools SCREENflex™ and CI-SCREEN™ aim at all stages of the drug development process.
The SCREENflex™ technology creates stable transgenic cell lines 50-70% faster than conventional recombinant techniques. More importantly, the SCREENflex™ cell systems are of unparalleled quality with regard to expression levels and stability of the transgene.
The CI-SCREEN™ technology is an enabling tool. It creates physiological relevant cell systems in sufficient quantity for use in drug development campaigns.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Inhoffenstrasse 7, Braunschweig,38124,germany
- Industry
- Biotechnology
- Website
- inscreenex.com
- HQ
- Braunschweig
Inscreenex Gmbh Questions
Inscreenex Gmbh's website is inscreenex.com
Inscreenex Gmbh's LinkedIn profile is https://de.linkedin.com/company/inscreenex
Inscreenex Gmbh has
8 employees.
View email and phone details for 8
employees at Inscreenex Gmbh.
Inscreenex Gmbh's industry is
Biotechnology
Inscreenex Gmbh's top competitors are
Athebio Ag,
Yumab Gmbh,
Abcalis Gmbh,
Biofidus Ag,
Iba Lifesciences,
Laserscanning Europe Gmbh,
Cytion,
Valerius Biopharma Ag,
Progen,
Corat Therapeutics Gmbh.
Inscreenex Gmbh's categories are Biotechnology
Inscreenex Gmbh's founding year is 2009
